REGistry of Long-term AnTithrombotic TherApy-1 (REGATTA-1)

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Status: Enrolling

Conditions: Peripheral Artery Disease; Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

Treatments: Drug: Antiplatelet Drug

Study type: Observational

Funder types: Other

Identifiers

NCT04347200

REGATTA119021970

Details and patient eligibility

About

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes

Full description

The register is a Russian prospective single-center observational study of patients who have indications for long-term antithrombotic therapy in connection with chronic coronary syndromes

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging

Exclusion criteria

• Subjects who are unwilling or unable to provide informed consent.
• Acute coronary syndrome within 12 months before inclusion
• Severe chronic heart failure (NYHA IV)
• Stroke within 6 months before inclusion
• Severe liver or muscle disease
• Severe kidney disease / renal failure with creatinine > 3 mg/dl
• Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention -